Document Detail


Why minimal is not optimal: driving the mammalian cell cycle--and drug discovery--with a physiologic CDK control network.
MedLine Citation:
PMID:  22732498     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Progression through the eukaryotic cell division cycle is governed by the activity of cyclin-dependent kinases (CDKs). For a CDK to become active it must (1) bind a positive regulatory subunit (cyclin) and (2) be phosphorylated on its activation (T) loop. In metazoans, multiple CDK catalytic subunits, each with a distinct set of preferred cyclin partners, regulate the cell cycle, but it has been difficult to assign functions to individual CDKs in vivo. Biochemical analyses and experiments with dominant-negative alleles suggested that specific CDK/cyclin complexes regulate different events, but genetic loss of interphase CDKs (Cdk2, -4 and -6), alone or in combination, did not block proliferation of cells in culture. These knockout and knockdown studies suggested redundancy or plasticity built into the CDK network but did not address whether there was true redundancy in normal cells with a full complement of CDKs. Here, we discuss recent work that took a chemical-genetic approach to reveal that the activity of a genetically non-essential CDK, Cdk2, is required for cell proliferation when normal cyclin pairing is maintained. These results have implications for the systems-level organization of the cell cycle, for regulation of the restriction point and G 1/S transition and for efforts to target Cdk2 therapeutically in human cancers.
Authors:
Karl A Merrick; Robert P Fisher
Related Documents :
22619528 - Oridonin nanosuspension was more effective than free oridonin on g2/m cell cycle arrest...
21036658 - Cell polarity and the control of apical growth in streptomyces.
20687468 - Understanding cytokinesis failure.
24065548 - Protective effect of mitochondrial ferritin on cytosolic iron dysregulation induced by ...
6282448 - Morphological, immunological, and biochemical analyses of chicken spleen cells transfor...
24098638 - Telomere reprogramming and maintenance in porcine ips cells.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2012-07-15
Journal Detail:
Title:  Cell cycle (Georgetown, Tex.)     Volume:  11     ISSN:  1551-4005     ISO Abbreviation:  Cell Cycle     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-07-25     Completed Date:  2012-11-26     Revised Date:  2013-07-16    
Medline Journal Info:
Nlm Unique ID:  101137841     Medline TA:  Cell Cycle     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2600-5     Citation Subset:  IM    
Affiliation:
Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cyclin-Dependent Kinase 2 / metabolism
Cyclin-Dependent Kinases / antagonists & inhibitors,  metabolism*
Cyclins / metabolism
Drug Evaluation, Preclinical
G1 Phase
Gene Targeting
HCT116 Cells
Humans
S Phase
Grant Support
ID/Acronym/Agency:
GM056985/GM/NIGMS NIH HHS
Chemical
Reg. No./Substance:
0/Cyclins; EC 2.7.11.22/Cyclin-Dependent Kinase 2; EC 2.7.11.22/Cyclin-Dependent Kinases
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fenofibrate-induced nuclear translocation of FoxO3A triggers Bim-mediated apoptosis in glioblastoma ...
Next Document:  The conserved C terminus of Claspin interacts with Rad9 and promotes rapid activation of Chk1.